Hyperphosphatemia is an important determinant of morbidity and mortality in patients with chronic kidney disease (CKD). Patients with CKD are advised to consume a low phosphate diet and are often prescribed phosphate-lowering drug therapy. However, commercially processed food and drinks often contain phosphate compounds, but the phosphate level is not usually provided in the ingredient list, which makes it difficult for CKD patients to choose a correct diet. We conducted a survey of the awareness of food/beverages containing artificially added phosphate among CKD patients undergoing hemodialysis. The subjects were 153 patients (77 males and 76 females; average age 56±11 years) who were randomly selected from the Dialysis Center of Hirosaki City, Japan. The subjects were provided with a list of questions. The survey results showed that 93% of the subjects were aware of the presence of high sugar content in soda, whereas only 25% were aware of the presence of phosphate (phosphoric acid) in such drinks. Despite 78% of the subjects being aware of the detrimental effects of consumption of a high phosphate diet, 43% drank at least 1 to 5 cans of soda per week and about 17% consumed “fast food” once each week. We also assessed the immediate effects of high-phosphate containing carbonated soda consumption by determining urinary calcium, phosphate, protein and sugar contents in overnight fasted healthy volunteers (n = 55; average age 20.7±0.3 years old, 20 males and 35 females). Significantly higher urinary calcium (adjusted using urinary creatinine) excretion was found 2 h after consuming 350 ml of carbonated soda compared to the fasting baseline level (0.15±0.01 vs. 0.09±0.01, p = 0.001). Our survey results suggest that CKD patients undergoing hemodialysis are not adequately aware of the hidden source of phosphate in their diet, and emphasize the need for educational initiatives to raise awareness of this issue among CKD patients.
Citation: Shutto Y, Shimada M, Kitajima M, Yamabe H, Saitoh Y, Saitoh H, et al. (2013) Inadequate Awareness among Chronic Kidney Disease Patients Regarding Food and Drinks Containing Artificially Added Phosphate. PLoS ONE 8(11): e78660. doi:10.1371/journal.pone.0078660
Editor: Emmanuel A. Burdmann, University of Sao Paulo Medical School, Brazil
Received: February 1, 2012; Accepted: September 21, 2013; Published: November 13, 2013
Copyright: © 2013 Shutto et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Dysregulation of phosphate balance can affect the functionality of most organ systems , , , , , , , , . Several studies have shown that hyperphosphatemia is the single most important determinant of mortality in CKD patients undergoing hemodialysis , , perhaps due to cardiovascular damage , , . Excessive retention of phosphate can cause extensive cellular and tissue damage, and a higher incidence of vascular calcification related to hyperphosphatemia is found in patients with CKD , , . Phosphate toxicity has been associated with cardiovascular calcification in various genetically modified mouse models , , , . More importantly, reduction of serum phosphate levels in these models can markedly suppress vascular calcification, despite the presence of significantly higher serum calcium and 1,25- dihydroxyvitamin D levels , . In patients with CKD, hyperphosphatemia and low serum vitamin D levels are independent risk factors for high mortality , , . Therefore, reducing serum phosphate in patients with CKD is a therapeutic priority, and these patients are often asked to consume a low-phosphate diet, in addition to taking phosphate-lowering drugs. Hence, it is important for CKD patients to be aware of food items and beverages that are rich in artificially added phosphates.
Organic and inorganic forms of phosphate are present in meat, fish, eggs, milk/dairy products, and vegetables. These foods are required for maintaining normal nutritional balance and avoidance of these foods is not a suitable option. However, CKD patients may need to reduce intake of some of these food items as required to minimize phosphate intake. Of particular importance, processed food items and beverages are rich in phosphate. Therefore, total phosphate ingestion is likely to be increased significantly by consumption of processed food and soda.
Developing awareness of food items and drinks containing artificially added phosphate is becoming more important because of widespread use of phosphate as a preservative in processed food items, which complicates the ability of CKD patients to reduce phosphate intake. To assess the level of awareness of CKD patients regarding food and drinks containing artificially added phosphate, we conducted a survey of CKD patients undergoing hemodialysis in multiple dialysis centers in Hirosaki, Japan. We also assessed the immediate effects of consumption of carbonated soda with a high-phosphate content in overnight fasted healthy volunteers by determining urinary calcium, phosphate, protein and sugar contents before and 2 hours after consumption of 350 ml of soda.
The subjects were 153 randomly selected CKD patients (77 males, 76 females) undergoing hemodialysis who are currently enrolled at the Dialysis Center in Hirosaki City, Japan. The average age of the subjects was 56±11 years old. All patients participated voluntarily on the assurance of anonymity, and none refused to answer the survey questions. A questionnaire consisting of seven questions was used to assess each patient's level of awareness about food and drinks containing artificially added phosphate (Table S1). The survey was conducted in June 2011. Informed consent was collected from each subject. All participation was on a volunteer basis and no financial compensation was offered. The results of the survey were analyzed using Microsoft Excel 2007 and IBM SPSS Statistics 19. A Mann-Whitney U test was used for comparison between groups.
Effects of consumption of carbonated soda
The subjects in this study were 55 Hirosaki University students (average age 20.7±0.3 years old; 20 males, 35 females) who were randomly divided into a group that drank 350 ml of carbonated soda (n = 35; average age 21.2±0.4 years old; 13 males, 22 females) and a control group (n = 20; average age 19.9±0.3 years old; 7 males, 13 females) who drank 350 ml of water, both after an overnight fast. Urine samples were collected before and 2 hours after drinking the soda or water. Urinary protein contents and glucose were determined qualitatively in both samples of urine using test paper, and the amounts of urinary phosphate, calcium and creatinine were measured in both samples using an auto-analyzer. The urinary phosphate and calcium levels were normalized using the urinary creatinine concentration. Data were analyzed using a Wilcoxon signed-rank test and a Pearson correlation test, with a value of p<0.05 considered to be significant. The survey and the carbonated soda study were approved by the Committee for Medical Ethics of Hirosaki University, Japan.
Results and Discussion
To determine the level of awareness of food and drinks containing artificially added phosphate, we conducted a survey on CKD patients undergoing hemodialysis at the Dialysis Center in Hirosaki City, Japan. Since patients with CKD are required to maintain a low-phosphate diet, it is important that they are fully aware of food items (hamburgers and pizza) and beverages (soda) that contain artificially added phosphate. Based on this survey, 93% of the CKD patients were aware of the high sugar content in soda, but only 25% were aware of the presence of phosphate (phosphoric acid) in similar drinks. Similarly, 46% of the CKD patients were not aware that phosphate, in the form of a preservative, is routinely added to processed foods such as hamburgers and pizza (Figure 1). The survey results, categorized by gender, are shown in Table S2. It is clear from the survey that the CKD patients were often uninformed about the phosphate content in food and drinks, and therefore did not understand the detrimental effect of consuming such items.
Almost 93% of the participants were aware of the presence of sugar, while only 25% were aware of the presence of phosphate (phosphoric acid) in such drink, showing a noticeable awareness gap related to phosphate-contenting drinks among the patients.
More importantly, despite 78% of the surveyed patients being aware of the detrimental effects of consumption of a high phosphate diet, 43% drank at least 1 to 5 cans of soda per week, while another 5% consumed 6 to 10 cans of soda per week. About 17% of the surveyed patients ate fast food (hamburgers, pizza, etc.) once each week and another 22% consumed these items once each month (Figure 2). The survey results categorized by age groups are shown in Table S3.
Almost half (51%) of the CKD patients drink soda, while 39% patients eat fast food.
The majority (78%) of the CKD patients in the survey did appreciate the risk of consuming high phosphate-containing food and drinks (Figure 3). These responses differed significantly from those of medical and nursing students, since only 32% of the students were aware of the risks associated with uncontrolled phosphate consumption . Despite 87% of the CKD patients recognizing the impact of phosphate on disease progression, only 25% were aware that most soda contains a phosphate compound (phosphoric acid).
The results of the survey clearly suggest that many CKD patients lack awareness of the presence of phosphate in food and drinks. However, after explaining this issue to the patients, 35% were eager to obtain information related to food containing phosphate and 45% were willing to consider reducing their phosphate intake by minimizing consumption of processed food and soda (Figure 4). These findings show the potential benefits of education of patients. Such educational guidance of CKD patients to make healthier food choices is likely to help in reducing complications related to abnormal mineral ion metabolism , , , , which is particularly important, given that the global prevalence of CKD may be as high as 500 million .
Around 35% of the participants wanted to have more information related to artificially containing-food and drinks, and another 45% were willing to reduce their phosphate intake by minimizing consumption of processed food and soda drinks.
Notably, almost half of the surveyed Japanese patients did not consume any soda (Figure 2). One reasons for this result may be their strong preference for green tea, since almost 87% of Japanese adults (40 to 69 years old; n = 13,916) have been found to consume green tea every day . Therefore, availability of an alternative healthy drink may reduce consumption of soda with high levels of sugar and phosphate.
The awareness of a majority (78%) of the subjects regarding effects related to a high-phosphate diet (Figure 3) indicates that healthcare providers, including doctors, nurses, and nutritionists, have been effective in informing patients of phosphate-related complications. However, an important finding in the survey was that about half (51%) of the CKD patients drank soda and 39% ate fast food (Figure 2), despite the high level of awareness of phosphate-related harmful effects. This may be explained by the fact that 75% of the surveyed patients did not realize that carbonated soda contains high levels of phosphate (Figure 1). Similarly, half of the surveyed patients were not aware of the high phosphate content in fast food and processed food items.
In summary, our results make it clear that there is an awareness gap among CKD patients regarding phosphate-containing foods and drinks. An issue that needs further evaluation, but is not within the scope of this survey, is the level to which healthcare providers are informing patients of the risk of a high-phosphate diet without providing sufficient details of the kind of foods and drinks that contain high phosphate. The results of this survey highlight a gap between the patients and healthcare providers, in terms of education of patients on foods with high phosphate levels. Of particular importance, the absence of listing of phosphate content in the nutritional ingredients makes it harder for patients to avoid food containing higher levels of phosphate.
A limitation of the study is that most of the surveyed patients drank soda and/or ate fast food due to lack of awareness of the phosphate content, and therefore we did not have enough patients to form a control group of non-consumers of these products. However, studies in overnight-fasted healthy volunteers show excretion of significantly increased amounts of urinary calcium at two hours after drinking soda, suggesting that the high phosphate content in the drink can influence other mineral metabolism. In the current study, the mean level of urinary calcium (adjusted using urinary creatinine) in 35 overnight fasted volunteers increased significantly from before to 2 hours after consuming 350 ml of carbonated soda (0.09±0.01 vs. 0.15±0.01, p = 0.001). In contrast, there was no such change in urinary calcium excretion from before to after drinking water in 20 control subjects. Urinary phosphate levels (adjusted using urinary creatinine) showed a slight, but not significant, increase from before to 2 hours after soda consumption (0.33±0.03 vs. 0.36±0.03, p = 0.252), and was unchanged in samples collected from the controls. A urinary analysis did not detect abnormal excretion of urinary protein and sugar in samples collected before and after drinking soda or water (data not shown).
The long-term effects of soda consumption on mineral ion metabolism were not examined in this study. This issue requires further study to show that increased serum phosphate levels in patients consuming fast food and soda are not harmless, and that the high-phosphate diet cannot be justified. In fact, it is becoming more evident from experimental and human studies that features of phosphate toxicity can appear after consumption of a high-phosphate diet, even when serum phosphate levels are within the normal range , .
The results of the survey highlight two important points. First, CKD patients are not sufficiently aware of food items and drinks that contain artificially added phosphates. Second, there is a need for an educational initiative to raise awareness of the risks posed by dietary items with hidden phosphate content.
List of Questioner.
Survey results categorized by gender.
Survey results categorized by different age groups.
Thanks are due to Dr. Satoko Osuka (MD), for help in finding the sources of Japanese phosphate-containing food and drinks.
Conceived and designed the experiments: HY MSR. Performed the experiments: Y. Shutto MS MK Y. Saitoh HS. Analyzed the data: Y. Shutto MS MK HY. Contributed reagents/materials/analysis tools: Y. Shutto, MS MK Y. Saitoh HS HY. Wrote the paper: MSR.
- 1. Razzaque MS (2011) Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) 120: 91–97.
- 2. Econs MJ (1999) New insights into the pathogenesis of inherited phosphate wasting disorders. Bone 25: 131–135.
- 3. Razzaque MS (2011) Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life 63: 240–247.
- 4. Snively CS, Gutierrez C (2004) Chronic kidney disease: prevention and treatment of common complications. Am Fam Physician 70: 1921–1928.
- 5. Razzaque MS (2009) The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5: 611–619.
- 6. Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, et al. (2009) Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. Br J Pharmacol 156: 1267–1278.
- 7. Razzaque MS (2009) FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol 296: F470–476.
- 8. Ohnishi M, Razzaque MS (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24: 3562–3571.
- 9. Razzaque MS (2011) The dualistic role of vitamin D in vascular calcifications. Kidney Int 79: 708–714.
- 10. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520–528.
- 11. Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, et al. (2010) Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 5: 2251–2257.
- 12. Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27: 220–230.
- 13. Block G, Port FK (2003) Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease. Semin Dial 16: 140–147.
- 14. Hruska K, Mathew S, Lund R, Fang Y, Sugatani T (2011) Cardiovascular risk factors in chronic kidney disease: does phosphate qualify Kidney Int Suppl: S9–13.
- 15. Fukagawa M, Hamada Y, Nakanishi S, Tanaka M (2006) The kidney and bone metabolism: Nephrologists' point of view. J Bone Miner Metab 24: 434–438.
- 16. Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009) In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet 2: 583–590.
- 17. Ohnishi M, Nakatani T, Lanske B, Razzaque MS (2009) Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int 75: 1166–1172.
- 18. Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, et al. (2009) In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J 23: 433–441.
- 19. Nakatani T, Ohnishi M, Razzaque MS (2009) Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 23: 3702–3711.
- 20. Voormolen N, Noordzij M, Grootendorst DC, Beetz I, Sijpkens YW, et al. (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22: 2909–2916.
- 21. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503–511.
- 22. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, et al. (2004) Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 19: 179–184.
- 23. Shutto Y, Shimada M, Kitajima M, Yamabe H, Razzaque MS (2011) Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks. PLoS One 6: e29105.
- 24. Molony DA, Stephens BW (2011) Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations. Adv Chronic Kidney Dis 18: 120–131.
- 25. Ahlenstiel T, Pape L, Ehrich JH, Kuhlmann MK (2010) Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant 25: 3241–3249.
- 26. Sigrist MK, Chiarelli G, Lim L, Levin A (2009) Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review. J Ren Care 35 Suppl 1: 71–78.
- 27. Ketteler M, Biggar PH (2009) Dietary and pharmacological control of calcium and phosphate metabolism in predialysis stages of chronic kidney disease. Blood Purif 27: 345–349.
- 28. Barsoum RS (2006) Chronic kidney disease in the developing world. N Engl J Med 354: 997–999.
- 29. Tokunaga S, White IR, Frost C, Tanaka K, Kono S, et al. (2002) Green Tea Consumption and Serum Lipids and Lipoproteins in a Population of Healthy Workers in Japan. Ann Epidemiol 12: 157–165.
- 30. Osuka S, Razzaque MS (2012) Can features of phosphate toxicity appear in normophosphatemia? J Bone Miner Metab 30: 10–18.
- 31. Razzaque MS (2013) Phosphate toxicity and vascular mineralization. Contrib Nephrol 180: 74–85.